Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,762 public trials 966 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

PSMA-PET Registry for Recurrent Prostate Cancer

NCT03718260

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • The Ottawa Hospital, General Campus Ottawa, Ontario, Canada
  • Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada
View Trial Details
Completed

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

NCT06604442

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Tower Urology Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Completed

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

NCT05467176

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Urology Associates of Mobile Mobile, Alabama, United States
  • Dignity Health Phoenix, Arizona, United States
  • Arizona Urology Specialists, PLLC Tucson, Arizona, United States
View all 96 locations
View Trial Details
Completed

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

NCT04037254

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 95 locations
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

NCT03834493

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0065) Mobile, Alabama, United States
  • Providence Medical Foundation-Oncology ( Site 0069) Fullerton, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0081) Los Angeles, California, United States
  • University of Colorado Cancer Center ( Site 0022) Aurora, Colorado, United States
View all 259 locations
View Trial Details
Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
View Trial Details

Related conditions